SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001578563-21-000038
Filing Date
2021-10-15
Accepted
2021-10-15 17:05:24
Documents
1
Period of Report
2021-10-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 9515
  Complete submission text file 0001578563-21-000038.txt   11648
Mailing Address BAYERWERK, GEBAEUDE W11 KAISER-WILHELM-ALLEE LEVERKUSEN 2M D-51368
Business Address BAYERWERK, GEBAEUDE W11 KAISER-WILHELM-ALLEE LEVERKUSEN 2M D-51368 492143081933
BAYER AKTIENGESELLSCHAFT (Reporting) CIK: 0001144145 (see all company filings)

Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40881 | Film No.: 211326610
SIC: 2834 Pharmaceutical Preparations

Mailing Address 800 BOYLSTON STREET SUITE 1555 BOSTON MA 02199
Business Address 800 BOYLSTON STREET SUITE 1555 BOSTON MA 02199 (617) 351-2575
Pyxis Oncology, Inc. (Issuer) CIK: 0001782223 (see all company filings)

IRS No.: 831160910 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ENERGIEWEG 1 MIJDRECHT P7 3641
Business Address ENERGIEWEG 1 MIJDRECHT P7 3641 00 31 297 280 666
Bayer World Investments B.V. (Reporting) CIK: 0001820027 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40881 | Film No.: 211326611